Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to make epidurals easier and more accurate

NCT ID NCT07458087

First seen Mar 10, 2026 · Last updated Jun 19, 2026 · Updated 13 times

Summary

This study will test a new ultrasound device called Accuro 3S that helps doctors see inside the back in real time while placing epidural or spinal needles. The goal is to see if it reduces the number of needle sticks and improves accuracy. About 50 patients needing these procedures will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURAXIAL TECHNIQUE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yale New Haven Hospital

    New Haven, Connecticut, 06520, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Accuro 3S device

What this could lead to

If successful, this device could make epidurals and spinal procedures easier and more accurate, potentially reducing patient discomfort and complications.

What could go wrong

This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The device may not improve accuracy or reduce needle attempts as hoped.

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.